AU2807089A - Tablet for use in the treatment of progesterone deficiency - Google Patents

Tablet for use in the treatment of progesterone deficiency

Info

Publication number
AU2807089A
AU2807089A AU28070/89A AU2807089A AU2807089A AU 2807089 A AU2807089 A AU 2807089A AU 28070/89 A AU28070/89 A AU 28070/89A AU 2807089 A AU2807089 A AU 2807089A AU 2807089 A AU2807089 A AU 2807089A
Authority
AU
Australia
Prior art keywords
progesterone
wax
safflower oil
level increases
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28070/89A
Other languages
English (en)
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAGYN Inc
Original Assignee
PHARMAGYN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAGYN Inc filed Critical PHARMAGYN Inc
Publication of AU2807089A publication Critical patent/AU2807089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU28070/89A 1987-10-05 1988-10-03 Tablet for use in the treatment of progesterone deficiency Abandoned AU2807089A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10480887A 1987-10-05 1987-10-05
US104808 1987-10-05
US23061688A 1988-08-10 1988-08-10
US230616 1988-08-10

Publications (1)

Publication Number Publication Date
AU2807089A true AU2807089A (en) 1989-04-18

Family

ID=26801969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28070/89A Abandoned AU2807089A (en) 1987-10-05 1988-10-03 Tablet for use in the treatment of progesterone deficiency

Country Status (6)

Country Link
EP (1) EP0335970B1 (de)
AT (1) ATE80037T1 (de)
AU (1) AU2807089A (de)
CA (1) CA1315681C (de)
DE (1) DE3874320T2 (de)
WO (1) WO1989002742A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
GB9921933D0 (en) 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
FR2821555B1 (fr) 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
WO2003065924A1 (en) 2002-02-08 2003-08-14 Advanced Animal Technology Limited Control of a biological function
US20060263429A1 (en) 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
FR2947178B1 (fr) * 2009-06-29 2012-07-06 Effik Composition pharmaceutique a base de progesterone micronisee et ses utilisations
EP3500246B1 (de) 2016-08-18 2021-08-04 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Tablettenformulierung gegen parkinson mit verbessertem auflösungsprofil

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880135A (en) * 1952-10-30 1959-03-31 Upjohn Co 11-keto-progesterone compositions and methods of treating ketosis therewith
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3193457A (en) * 1961-06-07 1965-07-06 Syntex Corp Oral administration of 6, 16alpha-dimethyl-progesterones
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3535419A (en) * 1965-12-15 1970-10-20 Syntex Corp Veterinary compositions and methods
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung

Also Published As

Publication number Publication date
DE3874320T2 (de) 1992-12-17
DE3874320D1 (de) 1992-10-08
CA1315681C (en) 1993-04-06
EP0335970A4 (de) 1990-03-28
WO1989002742A1 (en) 1989-04-06
ATE80037T1 (de) 1992-09-15
EP0335970A1 (de) 1989-10-11
EP0335970B1 (de) 1992-09-02

Similar Documents

Publication Publication Date Title
DE3470662D1 (en) Aqueous or anhydrous cosmetic composition containing a fatty phase based on karite oil
AU6377090A (en) Bread improver compositions
AU597822B2 (en) Transparent antiperspirant stick compositions
ES8608974A1 (es) Procedimiento para preparar una composicion de polvo de tan-talo
GB8319073D0 (en) Fatty acid compositions
AU2807089A (en) Tablet for use in the treatment of progesterone deficiency
MY111149A (en) Improved fatty compositions with high solids content.
Guerrero et al. Characterization of type-II thyroxine 5′-deiodinase activity in rat Harderian gland
MY101192A (en) Stable flavour-containing dentifrice
IL92993A0 (en) Composition comprising gemfibrozil
ATE43332T1 (de) Glaszusammensetzungen zur verbindung mit legierungen.
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
ES8204279A1 (es) Procedimiento de modificacion artificial de las precipitaciones atmosfericos,.
ES2009249A6 (es) Composicion cosmetica regeneradora de la piel a base de algas que contengan selenio.
DE3474782D1 (en) Surface active agent compositions
AU560756B2 (en) Composition containing an essential fatty acid and brotin
ZA884162B (en) Acaricide formulations
CA2084211A1 (en) Moldable dental material and method
FI944162A (fi) Maustamattomia ratamojuomaseoskoostumuksia
Olszewski et al. Composition, particle size and organic matter content of the bottom sediments of man-made Lake Zegrzyñskie
GB2208517A (en) Middle distillate compositions with reduced wax crystal size
JPS55164278A (en) Preparation of gel cooling material
ES2038545A2 (es) Procedimiento para la fabricacion y aplicacion de piedra sintetica.
BG48622A1 (en) Plastificated polyvinylchloride composition
JPS649924A (en) Bathing composition